144 related articles for article (PubMed ID: 12426252)
21. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol.
Swystun VA; Gordon JR; Davis EB; Zhang X; Cockcroft DW
J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):57-64. PubMed ID: 10887306
[TBL] [Abstract][Full Text] [Related]
22. [Regulatory effects of inhaled steroids on expression of matrix metalloproteinase-9 and its inhibitor in asthmatic rats].
Qiao HM; Lu JR; Cheng HJ; Liu L; Ma QS; Fu WY; Zhao FX
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):591-4. PubMed ID: 16191269
[TBL] [Abstract][Full Text] [Related]
23. The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity.
Bruce C; Thomas PS
Toxicol Appl Pharmacol; 2005 Jun; 205(2):126-32. PubMed ID: 15893540
[TBL] [Abstract][Full Text] [Related]
24. Th17 response to Dermatophagoides pteronyssinus is related to late-phase airway and systemic inflammation in allergic asthma.
Bajoriuniene I; Malakauskas K; Lavinskiene S; Jeroch J; Sakalauskas R
Int Immunopharmacol; 2013 Dec; 17(4):1020-7. PubMed ID: 24161744
[TBL] [Abstract][Full Text] [Related]
25. Induced sputum-retrieved matrix metalloproteinase 9 and tissue metalloproteinase inhibitor 1 in granulomatous diseases.
Fireman E; Kraiem Z; Sade O; Greif J; Fireman Z
Clin Exp Immunol; 2002 Nov; 130(2):331-7. PubMed ID: 12390324
[TBL] [Abstract][Full Text] [Related]
26. Children with stable asthma have reduced airway matrix metalloproteinase-9 and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio.
Doherty GM; Kamath SV; de Courcey F; Christie SN; Chisakuta A; Lyons JD; Heaney LG; Ennis M; Shields MD
Clin Exp Allergy; 2005 Sep; 35(9):1168-74. PubMed ID: 16164443
[TBL] [Abstract][Full Text] [Related]
27. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
28. [MMP-9 and TIMP-1 levels in the sputum of patients with chronic obstructive pulmonary disease and asthma].
Calikoğlu M; Unlü A; Tamer L; Ozgür E
Tuberk Toraks; 2006; 54(2):114-21. PubMed ID: 16924566
[TBL] [Abstract][Full Text] [Related]
29. Determinants of allergen-induced late bronchial responses in mild asthmatics.
Alvarez-Puebla MJ; Olaguibel-Rivera JM; Urbiola-Marcilla E; Garcia BE; Tabar-Purroy AI
Chest; 2001 Jan; 119(1):120-7. PubMed ID: 11157593
[TBL] [Abstract][Full Text] [Related]
30. Levels of matrix metalloproteinase-9 and its inhibitor in bronchoalveolar lavage cells of asthmatic children.
Tang LF; Du LZ; Chen ZM; Zou CC
Fetal Pediatr Pathol; 2006; 25(1):1-7. PubMed ID: 16754484
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinases-7, -8, -9 and TIMP-1 in the follow-up of diisocyanate-induced asthma.
Piirilä P; Lauhio A; Majuri ML; Meuronen A; Myllärniemi M; Tervahartiala T; Vuorinen K; Laitinen A; Alenius H; Kinnula VL; Sorsa T
Allergy; 2010 Jan; 65(1):61-8. PubMed ID: 19804449
[TBL] [Abstract][Full Text] [Related]
32. Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: clinical correlates and prognostic implications.
Guan WJ; Gao YH; Xu G; Lin ZY; Tang Y; Gu YY; Liu GH; Li HM; Chen RC; Zhong NS
Respirology; 2015 Oct; 20(7):1073-81. PubMed ID: 26122009
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of fluticasone on allergen-induced airway responses and sputum inflammatory markers.
Parameswaran K; Inman MD; Watson RM; Morris MM; Efthimiadis A; Ventresca PG; Lam R; O'Byrne PM; Hargreave FE
Can Respir J; 2000; 7(4):313-9. PubMed ID: 10980457
[TBL] [Abstract][Full Text] [Related]
34. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA.
Cho JY; Miller M; McElwain K; McElwain S; Shim JY; Raz E; Broide DH
J Allergy Clin Immunol; 2006 Mar; 117(3):618-25. PubMed ID: 16522462
[TBL] [Abstract][Full Text] [Related]
35. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1.
Lee YM; Kim SS; Kim HA; Suh YJ; Lee SK; Nahm DH; Park HS
J Korean Med Sci; 2003 Feb; 18(1):97-102. PubMed ID: 12589095
[TBL] [Abstract][Full Text] [Related]
36. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects.
Gauvreau GM; Jordana M; Watson RM; Cockroft DW; O'Byrne PM
Am J Respir Crit Care Med; 1997 Dec; 156(6):1738-45. PubMed ID: 9412549
[TBL] [Abstract][Full Text] [Related]
37. [Differential cell count of sputum in patients with asthma challenged with allergen provocation].
Siergiejko Z; Michno T; Tomorowicz A
Pneumonol Alergol Pol; 2001; 69(3-4):185-92. PubMed ID: 11575003
[TBL] [Abstract][Full Text] [Related]
38. Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjögren's syndrome.
Asatsuma M; Ito S; Watanabe M; Takeishi H; Nomura S; Wada Y; Nakano M; Gejyo F; Igarashi A
Clin Chim Acta; 2004 Jul; 345(1-2):99-104. PubMed ID: 15193983
[TBL] [Abstract][Full Text] [Related]
39. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organizing pneumonia.
Choi KH; Lee HB; Jeong MY; Rhee YK; Chung MJ; Kwak YG; Lee YC
Chest; 2002 May; 121(5):1478-85. PubMed ID: 12006432
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
